RegeneRx Biopharmaceuticals, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Rockville MD United States (2002)

Organization Overview

First Clinical Trial
2006
NCT00311766
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

ReGenTree, LLC